COMMUNIQUÉS West-GlobeNewswire

Novan SB206 Phase 3 Molluscum Pivotal Program Update
11/07/2019
More than 50 percent of total expected patients now enrolled Virtually all of the clinical sites now active Discipline and execution focus remain of equal importance to recruitment activity MORRISVILLE, N.C., July 11, [...]
iCAD’s ProFound AI™ for 2D Mammography Receives CE Mark Approval
11/07/2019
Deep-learning, artificial intelligence technology assists radiologists in detecting breast cancer NASHUA, N.H., July 11, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing [...]
Atreca Further Strengthens Management Team with Appointment of Lisa Decker as Chief Business Officer and Courtney Phillips as General Counsel
11/07/2019
REDWOOD CITY, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, today [...]
NeuBase Therapeutics to Participate in Roth RNA Revolution Conference
11/07/2019
PITTSBURGH, July 11, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (“NeuBase”), a biotechnology company developing next generation antisense therapies to address genetic diseases, today announced that Dietrich [...]
Alder BioPharmaceuticals® Presents New Data on Migraine-Free Months, Migraine Severity and Quality of Life, Demonstrating Eptinezumab’s Clinical Profile for Migraine Prevention
11/07/2019
- Posters presented at the 2019 American Headache Society meeting highlight eptinezumab’s safety profile and suppression of calcitonin gene-related peptide (CGRP) - - New data show no migraine days experienced for six [...]
Avricore Health Announces Amendment to Placement Terms
11/07/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, July 11, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the " [...]
CareDx Applauds White House Efforts to Reform America’s Kidney Health System
11/07/2019
Executive Order outlines initiatives to make organ transplantation the preferred treatment option BRISBANE, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company [...]
Manasi Patwardhan Joins BioSig as Director of Strategic Planning
11/07/2019
BioSig enhances operational excellence through talent acquisition in program management and strategic planning from Fortune 500 background Westport, CT, July 11, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( [...]
Kura Oncology Expands Protection for Tipifarnib with New U.S. and European Patents
11/07/2019
SAN DIEGO, July 11, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced [...]
Cronos Group Enters Agreement to Acquire State-of-the-Art Fermentation and Manufacturing Facility
11/07/2019
Facility Advances Partnership with Ginkgo Bioworks; Will Enable Production of Cultured Cannabinoids at Commercial Scale TORONTO, July 11, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos [...]
Theratechnologies Announces Financial Results for the Second Quarter of 2019
11/07/2019
MONTREAL, July 11, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the second quarter ended May 31, 2019. Second quarter 2019 financial highlights [...]
Theratechnologies annonce ses résultats financiers pour le deuxième trimestre de 2019
11/07/2019
MONTRÉAL, 11 juill. 2019 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX : TH) a annoncé aujourd’hui ses résultats financiers pour le deuxième trimestre clos le 31 mai 2019. Faits saillants [...]
HEXO Corp to transfer listing to the New York Stock Exchange
11/07/2019
GATINEAU, Quebec, July 11, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE-A: HEXO) is pleased to announce it has received approval from the New York Stock Exchange (the “NYSE”) to transfer [...]
Transfert de l’inscription des actions d’HEXO Corp au New York Stock Exchange
11/07/2019
GATINEAU, Québec, 11 juill. 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO; NYSE-A: HEXO) est heureuse d’annoncer qu’elle a reçu l’approbation du New York Stock Exchange (« NYSE ») lui [...]
Precision Biomonitoring and Azimuth Environmental Consulting Announce business and technical agreement
11/07/2019
Industry leaders join forces to provide combined environmental DNA biomonitoring solutions to enhance delivery of reliable survey results to clients and increase workflow efficiencies GUELPH, Ontario and BARRIE, Ontario [...]
Forty Seven, Inc. and Ono Pharmaceutical Co., Ltd. Sign Regional License Agreement to Develop, Manufacture and Commercialize 5F9 in Japan, South Korea, Taiwan and Select Countries in Southeast Asia
11/07/2019
-- Ono to Receive Exclusive License for All Therapeutic Uses of 5F9 in Select Asian Markets -- -- Forty Seven to Receive up to $120M in Combined Upfront and Potential Development and Commercial Milestone Payments, in [...]
Natus Medical to Hold 2019 Second Quarter Financial Results Conference Call on July 25th
11/07/2019
PLEASANTON, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY), a leading provider of medical devices and services, today announced that the Company will release its 2019 second quarter [...]
Aleafia Health Added to NYSE-Listed The Cannabis ETF
11/07/2019
TORONTO, July 11, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”) has been added to The Cannabis ETF (NYSE: THCX) (“ THCX ”), which trades on the [...]
Emerald Health Therapeutics’ Joint Venture Achieves Its Full Annualized Production Run-Rate
11/07/2019
Pure Sunfarms Delta greenhouse continues to advance VANCOUVER, British Columbia, July 11, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc.’s (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) 50%-owned joint venture for [...]

Pages